was founded by Ruslan Medzhitov and Richard Flavell, both of Yale University and Howard Hughes Medical Institute and leaders in the field of innate immunity. The company started in 2002 with Michael Sherman serving as Chief Executive Officer and a research team in New Haven , CT. In 2004, the company expanded and established a development team and corporate headquarters in Cranbury , NJ . The company currently has approximately
60 employees including 13 with doctoral degrees.
Currently, VaxInnate occupies approximately
20,000 square feet of laboratory and office space in Cranbury , NJ. This includes molecular and cell biology labs, cell culture facilities, a protein pilot plant and analytical laboratory space.
$100 million to date and is backed by well-known venture capital firms, including HealthCare Ventures, Oxford Bioscience Partners LLC, MedImmune Ventures, Inc., CHL Medical Partners, New Leaf Venture Partners, Canaan Partners
and The Wellcome